Chromothriptic cure of WHIM syndrome: Implications for bone marrow transplantation

References

• Krill CE, Jr., Smith HD, Mauer AM. Chronic Idiopathic Granulocytopenia. N Engl J Med 1964; 270:973-9; PMID:14122792; http://dx.doi.org/10.1056/NEJM196405072701902
   PubMed Web of Science ®Google Scholar
• Zuelzer WW. “Myelokathexis”–a New Form of Chronic Granulocytopenia. Report of a Case. N Engl J Med 1964; 270:699-704; PMID:14101065; http://dx.doi.org/10.1056/NEJM196404022701402
   PubMed Web of Science ®Google Scholar
• McDermott DH, Gao JL, Liu Q, Siwicki M, Martens C, Jacobs P, Velez D, Yim E, Bryke CR, Hsu N, et al. Chromothriptic cure of WHIM syndrome. Cell 2015; 160:686-99; PMID:25662009; http://dx.doi.org/10.1016/j.cell.2015.01.014
   PubMed Web of Science ®Google Scholar
• Wetzler M, Talpaz M, Kleinerman ES, King A, Huh YO, Gutterman JU, Kurzrock R. A new familial immunodeficiency disorder characterized by severe neutropenia, a defective marrow release mechanism, and hypogammaglobulinemia. Am J Med 1990; 89:663-72; PMID:2239986; http://dx.doi.org/10.1016/0002-9343(90)90187-I
   PubMed Web of Science ®Google Scholar
• Hernandez PA, Gorlin RJ, Lukens JN, Taniuchi S, Bohinjec J, Francois F, Klotman ME, Diaz GA. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet 2003; 34:70-4; PMID:12692554; http://dx.doi.org/10.1038/ng1149
   PubMed Web of Science ®Google Scholar
• Haribabu B, Richardson RM, Fisher I, Sozzani S, Peiper SC, Horuk R, Ali H, Snyderman R. Regulation of human chemokine receptors CXCR4. Role of phosphorylation in desensitization and internalization. J Biol Chem 1997; 272:28726-31; PMID:9353342; http://dx.doi.org/10.1074/jbc.272.45.28726
   PubMed Web of Science ®Google Scholar
• Signoret N, Rosenkilde MM, Klasse PJ, Schwartz TW, Malim MH, Hoxie JA, Marsh M. Differential regulation of CXCR4 and CCR5 endocytosis. J Cell Sci 1998; 111 (Pt 18):2819-30; PMID:9718374
   PubMed Web of Science ®Google Scholar
• Venkatesan S, Rose JJ, Lodge R, Murphy PM, Foley JF. Distinct mechanisms of agonist-induced endocytosis for human chemokine receptors CCR5 and CXCR4. Mol Biol Cell 2003; 14:3305-24; PMID:12925765; http://dx.doi.org/10.1091/mbc.E02-11-0714
   PubMed Web of Science ®Google Scholar
• Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Ann Rev Immunol 1999; 17:657-700; PMID:10358771; http://dx.doi.org/10.1146/annurev.immunol.17.1.657
   PubMed Web of Science ®Google Scholar
• McDermott DH, Lopez J, Deng F, Liu Q, Ojode T, Chen H, Ulrick J, Kwatemaa N, Kelly C, Anaya-O'Brien S, et al. AMD3100 is a Potent Antagonist at CXCR4(R334X), a Hyperfunctional Mutant Chemokine Receptor and Cause of WHIM Syndrome. J Cell Mol Med 2011; 15:2071-81; PMID:21070597; http://dx.doi.org/10.1111/j.1582-4934.2010.01210.x
   PubMed Web of Science ®Google Scholar
• Dale DC, Bolyard AA, Kelley ML, Westrup EC, Makaryan V, Aprikyan A, Wood B, Hsu FJ. The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome. Blood 2011; 118:4963-6; PMID:21835955; http://dx.doi.org/10.1182/blood-2011-06-360586
   PubMed Web of Science ®Google Scholar
• McDermott DH, Liu Q, Ulrick J, Kwatemaa N, Anaya-O'Brien S, Penzak SR, Filho JO, Priel DA, Kelly C, Garofalo M, et al. The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome. Blood 2011; 118:4957-62; PMID:21890643; http://dx.doi.org/10.1182/blood-2011-07-368084
   PubMed Web of Science ®Google Scholar
• McDermott DH, Liu Q, Velez D, Lopez L, Anaya-O'Brien S, Ulrick J, Kwatemaa N, Starling J, Fleisher TA, Priel DA, et al. A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor. Blood 2014; 123:2308-16; PMID:24523241; http://dx.doi.org/10.1182/blood-2013-09-527226
   PubMed Web of Science ®Google Scholar
• Krivan G, Erdos M, Kallay K, Benyo G, Toth A, Sinko J, Goda V, Toth B, Marodi L. Successful umbilical cord blood stem cell transplantation in a child with WHIM syndrome. Eur J Haematol 2010; 84:274-5; PMID:19878273; http://dx.doi.org/10.1111/j.1600-0609.2009.01368.x
   PubMed Web of Science ®Google Scholar
• Furusato B, Mohamed A, Uhlen M, Rhim JS. CXCR4 and cancer. Pathol Int 2010; 60:497-505; PMID:20594270; http://dx.doi.org/10.1111/j.1440-1827.2010.02548.x
   PubMed Web of Science ®Google Scholar
• Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med 1996; 184:1101-9; PMID:9064327; http://dx.doi.org/10.1084/jem.184.3.1101
   PubMed Web of Science ®Google Scholar
• Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998; 393:595-9; PMID:9634238; http://dx.doi.org/10.1038/31269
   PubMed Web of Science ®Google Scholar
• Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, Bronson RT, Springer TA. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci U S A 1998; 95:9448-53; PMID:9689100; http://dx.doi.org/10.1073/pnas.95.16.9448
   PubMed Web of Science ®Google Scholar
• Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, Yoshida N, Kikutani H, Kishimoto T. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996; 382:635-8; PMID:8757135; http://dx.doi.org/10.1038/382635a0
   PubMed Web of Science ®Google Scholar
• Tachibana K, Hirota S, Iizasa H, Yoshida H, Kawabata K, Kataoka Y, Kitamura Y, Matsushima K, Yoshida N, Nishikawa S, et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 1998; 393:591-4; PMID:9634237; http://dx.doi.org/10.1038/31261
   PubMed Web of Science ®Google Scholar
• DiPersio JF, Micallef IN, Stiff PJ, Bolwell BJ, Maziarz RT, Jacobsen E, Nademanee A, McCarty J, Bridger G, Calandra G, et al. Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma. J Clin Oncol 2009; 27:4767-73; PMID:19720922; http://dx.doi.org/10.1200/JCO.2008.20.7209
   PubMed Web of Science ®Google Scholar
• Peled A, Petit I, Kollet O, Magid M, Ponomaryov T, Byk T, Nagler A, Ben-Hur H, Many A, Shultz L, et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999; 283:845-8; PMID:9933168; http://dx.doi.org/10.1126/science.283.5403.845
   PubMed Web of Science ®Google Scholar
• Hutter G, Nowak D, Mossner M, Ganepola S, Mussig A, Allers K, Schneider T, Hofmann J, Kucherer C, Blau O, et al. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med 2009; 360:692-8; PMID:19213682; http://dx.doi.org/10.1056/NEJMoa0802905
   PubMed Web of Science ®Google Scholar
• Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, Mudie LJ, Pleasance ED, Lau KW, Beare D, Stebbings LA, et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 2011; 144:27-40; PMID:21215367; http://dx.doi.org/10.1016/j.cell.2010.11.055
   PubMed Web of Science ®Google Scholar
• Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Bone Marrow Trans 2012; 47:337-41; PMID:22395764; http://dx.doi.org/10.1038/bmt.2012.5
   PubMed Web of Science ®Google Scholar
• Cheng JK, Alper HS. The genome editing toolbox: a spectrum of approaches for targeted modification. Curr Opin Biotechnol 2014; 30C:87-94; http://dx.doi.org/10.1016/j.copbio.2014.06.005
   Web of Science ®Google Scholar